Las Condes

57 / 144

337
7. Miranda M. Mutación del gen LRRK2 se asocia a presentación
autosómica dominante de la enfermedad de Parkinson en una
familia chilena. Rev Med Chil. 2007;135(3):406–7.
8. Sinning M, Van Rooyen JP, Venegas-Francke P, Vásquez C,
Behrens MI, Ramírez A. Clinical and genetic analysis of
a chilean family with early-onset autosomal dominant
Alzheimer’s disease. J Alzheimer’s Dis. 2010;21(3):757–61.
9. Ramirez A, Heimbach A, Gründemann J, Stiller B, Hampshire D,
Cid LP, et al. Hereditary parkinsonism with dementia is caused
by mutations in ATP13A2, encoding a lysosomal type 5 P-type
ATPase. Nat Genet [Internet]. 2006;38(10):1184–91. Available
from: \
pdf
10. Margarit SB, Alvarado M, Alvarez K, Lay-Son G. Medical
genetics and genetic counseling in Chile. In: Journal of Genetic
Counseling. 2013. p. 869–74.
11. Goldman JS, Hahn SE, Catania JW, LaRusse-Eckert S,
Butson MB, Rumbaugh M, et al. Genetic counseling and
testing for Alzheimer disease: joint practice guidelines
of the American College of Medical Genetics and the
National Society of Genetic Counselors. Genet Med
[Internet]. 2011;13(6):597–605. Available from:
h t t p : / / www . p u bme d c e n t r a l . n i h . g o v / a r t i c l e r e n d e r .
fcgi?artid=3326653&tool=pmcentrez&rendertype=abstract
12. Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia
A, Dutra A, et al. Mutation in the alpha-synuclein gene
identified in families with Parkinson’s disease. Science.
1997;276(5321):2045–7.
13. Singleton a B, Farrer M, Johnson J, Singleton a, Hague S,
Kachergus J, et al. alpha-Synuclein locus triplication causes
Parkinson’s disease. Science. 2003;302(5646):841.
14. Wider C, Ross O a, Wszolek ZK. Genetics of Parkinson disease and
essential tremor. Curr Opin Neurol [Internet]. 2010;23(4):388–93.
Available from:
fcgi?artid=3930090&tool=pmcentrez&rendertype=abstract
15. Zimprich A, Biskup S, Leitner P, Lichtner P, Farrer M, Lincoln
S, et al. Mutations in LRRK2 cause autosomal-dominant
parkinsonism with pleomorphic pathology. Neuron.
2004;44(4):601–7.
16. Djarmati A, Hedrich K, Svetel M, Schäfer N, Juric V, Vukosavic S,
et al. Detection of Parkin (PARK2) and DJ1 (PARK7) mutations
in early-onset Parkinson disease: Parkin mutation frequency
depends on ethnic origin of patients. Hum Mutat [Internet].
2004;23(5):525. Available from:
gov/pubmed/15108293
17. Lucking CB, Durr A, Bonifati V, Vaughan J, De Michele G,
Gasser T, et al. Association between early-onset Parkinson’s
disease and mutations in the parkin gene. French Parkinson’s
Disease Genetics Study Group. N Engl J Med [Internet].
2000;342(21):1560–7. Available from: PM:10824074
18. Singleton AB, Farrer MJ, Bonifati V. The genetics of Parkinson’s
disease: Progress and therapeutic implications. Movement
Disorders. 2013. p. 14–23.
19. Cruts M, Van Duijn CM, Backhovens H, Van Den Broeck
M, Wehnert A, Serneels S, et al. Estimation of the genetic
contribution of presenilin-1 and -2 mutations in a population-
based study of presenile Alzheimer disease. Hum Mol Genet.
1998;7(1):43–51.
20. Bettens K, Sleegers K, Van Broeckhoven C. Genetic insights in
Alzheimer's disease [Internet]. The Lancet Neurology
2013. Available from:
article/pii/S1474442212702594
21. DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker
M, Rutherford NJ, et al. Expanded GGGGCC Hexanucleotide
Repeat in Noncoding Region of C9ORF72 Causes Chromosome
9p-Linked FTD and ALS. Neuron. 2011;72(2):245–56.
22. Shoulson I, Young AB. Milestones in huntington disease.
Movement Disorders. 2011. p. 1127–33.
[DIAGNÓSTICO GENÉTICO PARA ENFERMEDADES NEURODEGENERATIVAS. UN IMPORTANTE DESAFÍO PARA CHILE - Dr. Marcelo Miranda C. y col.]